登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
L × i.d.:
15 cm × 2.1 mm
Particle size:
3 μm
Matrix active group:
C18 (RP18), C18 (octadecyl) phase
Pore size:
100 Å
Matrix:
fully porous particle, silica gel high purity, spherical
产品名称
Ascentis ® C18 HPLC 色谱柱, 3 μm particle size, L × I.D. 15 cm × 2.1 mm
material
stainless steel column
Quality Segment
agency
suitable for USP L1 (Similar to Phenomenex Luna C18)
product line
Ascentis®
feature
endcapped
manufacturer/tradename
Ascentis®
packaging
1 ea of
extent of labeling
25% Carbon loading
parameter
≤70 °C temp. range, 400 bar pressure (5801 psi)
technique(s)
HPLC: suitable, LC/MS: suitable
L × I.D.
15 cm × 2.1 mm
surface area
450 m2/g
surface coverage
3.7 μmol/m2
impurities
<5 ppm metals
matrix
fully porous particle, silica gel high purity, spherical
matrix active group
C18 (RP18), C18 (octadecyl) phase
particle size
3 μm
pore size
100 Å
operating pH range
2-8
application(s)
PFAS testing
food and beverages
separation technique
reversed phase
General description
Ascentis 系列色谱柱是 Supelco 科学家推出的第四代 HPLC 色谱柱技术。Ascentis 系列色谱柱是以高纯硅胶为基质,孔径 100Å,硅胶粒径为 3、5 和 10 微米。该色谱柱用于小分子的应用,柱内径可从微径柱(1.0mm 内径)扩展到制备尺寸(50mm 内径)。该系列包括 C18、C8、苯基、Si 和内嵌极性基团相(反相酰胺)。
Ascentis C18 是特别稳定可靠的首选 HPLC 色谱柱,即使对于难以分离的化合物也能提供对称的峰形和出色的保留性能。
Ascentis C18 是特别稳定可靠的首选 HPLC 色谱柱,即使对于难以分离的化合物也能提供对称的峰形和出色的保留性能。
Application
- A Comparative Study on Analysis of Ginsenosides in American Ginseng Root Residue by HPLC-DAD-ESI-MS and UPLC-HRMS-MS/MS.: This paper compares methodologies involving the Ascentis® C18 HPLC Column for analyzing ginsenosides, showcasing the column′s utility in herbal medicine research (Hsu et al., 2022).
- Validation of a Rapid and Easy-to-Apply Method to Simultaneously Quantify Co-Loaded Dexamethasone and Melatonin PLGA Microspheres by HPLC-UV: Encapsulation Efficiency and In Vitro Release.: Demonstrates the use of the Ascentis® C18 HPLC Column in developing a validated HPLC-UV method for analyzing complex drug delivery systems, highlighting the column′s versatility (Brugnera et al., 2022).
- Simultaneous determination of ivermectin, clorsulon and their related substances in an injectable finished product by a stability-indicating RP-HPLC method.: Utilizes the Ascentis® C18 HPLC Column to ensure the stability and quality of veterinary pharmaceuticals, underlining the column′s application in regulatory compliance (Padivitage et al., 2022).
Features and Benefits
- 出色的保留性能
- 优良的峰形对称性
- 重现性好
- 与 LC-MS 完全兼容
Legal Information
Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under Ascentis ® C18 HPLC 色谱柱
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable